Edwards Lifesciences Corp/ US28176E1082 /
| 2024-04-16 7:15:29 PM | Chg. +0.79 | Volume | Bid- | Ask7:15:33 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 89.99USD | +0.89% | 78,970 Turnover: 7.06 mill. |
-Bid Size: - | 120.00Ask Size: 100 | 53.97 bill.USD | - | 38.85 |
Assets
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 482.5000 | 580 | 679.7000 | 867.5000 | 1,060.3000 | ||||||
| Intangible Assets | 205.4000 | 204.8000 | 468 | 343.2000 | 336.5000 | ||||||
| Long-Term Investments | 379.9000 | 532.1000 | 567 | 506.3000 | 585.5000 | ||||||
| Fixed Assets | 2,011.4000 | 2,270 | 3,163.7000 | 3,036.8000 | 3,504.1000 | ||||||
| Inventories | 339.9000 | 396.6000 | 554.9000 | 607 | 640.9000 | ||||||
| Accounts Receivable | 315.4000 | 365.5000 | 421.6000 | 456.9000 | 543.6000 | ||||||
| Cash and Cash Equivalents | 718.4000 | 930.1000 | 818.3000 | 714.1000 | 1,179.1000 | ||||||
| Current Assets | 2,047.9000 | 2,240 | 2,532.1000 | 2,286.9000 | 2,984 | ||||||
| Total Assets | 4,059.3000 | 4,510 | 5,695.8000 | 5,323.7000 | 6,488.1000 | ||||||
Liabilities
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 63.9000 | 97.1000 | 116.6000 | 134 | 180.4000 | ||||||
| Long-term debt | 599.9000 | 822.3000 | 438.4000 | 593.8000 | 594.4000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 412.3000 | 435.4000 | 636.6000 | 876.6000 | 696.5000 | ||||||
| Liabilities | 1,556.2000 | 1,891 | 2,739.6000 | 2,183.3000 | 2,339.8000 | ||||||
| Share Capital | 717.3000 | 727.8000 | 636 | 645.6000 | 654.3000 | ||||||
| Total Equity | 2,503.1000 | 2,619 | 2,956.2000 | 3,140.4000 | 4,148.3000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 4,059.3000 | 4,510 | 5,695.8000 | 5,323.7000 | 6,488.1000 | ||||||
Income Statement
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,493.7000 | 2,963.7000 | 3,435.3000 | 3,722.8000 | 4,348 | ||||||
| Depreciation (total) | 65.8000 | - | - | - | - | ||||||
| Operating Result | - | - | 1,089.4000 | 748.2000 | 1,146.8000 | ||||||
| Interest Income | 9.3000 | 8.4000 | 2.9000 | -2.1000 | -11.5000 | ||||||
| Income Before Taxes | 622.4000 | 737.9000 | 1,034.9000 | 761.4000 | 1,166.5000 | ||||||
| Income Taxes | 127.5000 | 168.4000 | 451.3000 | 39.2000 | 119.6000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 494.9000 | 569.5000 | 583.6000 | 722.2000 | 1,046.9000 | ||||||
Per Share
Cash Flow
| 2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 549.7000 | 704.4000 | 1,000.7000 | 926.8000 | 1,179.4000 | ||||||
| Cash Flow from Investing Activities | -316.1000 | -211.7000 | -647.2000 | 76.7000 | -595.8000 | ||||||
| Cash Flow from Financing | -158.6000 | -268.5000 | -473.2000 | -1,101.2000 | -115.6000 | ||||||
| Decrease / Increase in Cash | 64.6000 | 211.7000 | -111.8000 | -104.2000 | 465 | ||||||
| Employees | 9,800 | 11,100 | 12,200 | 12,800 | 13,900 | ||||||
